Experts say trial provides further evidence that attacking the build-up of proteins in the brain can slow the progression of the disease.An experimental Alzheimer's drug has been shown to slow significantly the cognitive and functional decline linked to the disease in results hailed as remarkable by experts, despite some patients experiencing serious side effects.
[
add
]
[
|
|
...
]